TY - JOUR T1 - Conditionally positive: a qualitative study of public perceptions about using health data for artificial intelligence research JF - medRxiv DO - 10.1101/2020.04.25.20079814 SP - 2020.04.25.20079814 AU - Melissa D McCradden AU - Tasmie Sarker AU - P Alison Paprica Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/01/2020.04.25.20079814.abstract N2 - Objectives Given widespread interest in applying artificial intelligence (AI) to health data to improve patient care and health system efficiency, there is a need to understand the perspectives of the general public regarding the use of health data in AI research.Design A qualitative study involving six focus groups with members of the public. Participants discussed their views about AI in general, then were asked to share their thoughts about three realistic health AI scenarios. Data were analysed using qualitative description thematic analysis.Settings Two cities in Ontario, Canada: Sudbury (400 km north of Toronto) and Mississauga, (part of the Greater Toronto Area).Participants Forty-one purposively sampled members of the public (21M:20F, 25-65 years, median age 40).Results Participants had low levels of prior knowledge of AI and mixed, mostly negative, perceptions of AI in general. Most endorsed AI as a tool for the analysis of health data when there is strong potential for public benefit, providing that concerns about privacy, consent, and commercial motives were addressed. Inductive thematic analysis identified AI-specific hopes (e.g., potential for faster and more accurate analyses, ability to use more data), fears (e.g., loss of human touch, skill depreciation from over-reliance on machines) and conditions (e.g., human verification of computer-aided decisions, transparency). There were mixed views about whether consent is required for health data research, with most participants wanting to know if, how and by whom their data were used. Though it was not an objective of the study, realistic health AI scenarios were found to have an educational effect.Conclusions Notwithstanding concerns and limited knowledge about AI in general, most members of the general public in six focus groups in Ontario, Canada perceived benefits from health AI and conditionally supported the use of health data for AI research.STRENGTHS AND LIMITATIONS OF THIS STUDY A strength of this study is the analysis of how diverse members of the general public perceive three realistic scenarios in which health data are used for AI research.The detailed health AI scenarios incorporate points that previous qualitative research has indicated are likely to elicit discussion (e.g., use of health data without express consent, involvement of commercial organisations in health research, inability to guarantee anonymity of genetic data) and may also be useful in future qualitative research studies and for educational purposes.The findings are likely to be relevant to organisations that are considering making health data available for AI research and development.Notwithstanding the diverse ethnic and educational backgrounds of participants, overall the sample represents the general (mainstream) population of Ontario and results cannot be interpreted as presenting the views of specific subpopulations and may not be generalisable across Ontario or to other settings.Given the low level of knowledge about AI in general it is possible that the views of participants would change substantially if they learned and understood more about AI.TRANSPARENCY STATEMENT P. Alison Paprica affirms that the manuscript is an honest, accurate and transparent account of the study being reported; that no important aspects of the study have been omitted; and that there were no discrepancies from the study as originally approved by the University of Toronto Research Ethics Board.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the Vector InstituteAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data relevant to the study are included in the article. All authors had access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. No unpublished data are available outside of the study team. ER -